Skip to main content
. Author manuscript; available in PMC: 2020 Feb 1.
Published in final edited form as: J Immunother. 2019 Feb-Mar;42(2):65–72. doi: 10.1097/CJI.0000000000000250

Figure 5:

Figure 5:

NK cell density and use of denileukin diftitox or total body irradiation. A) Box-and-whisker plots showing the distribution of CD56 positive NK cell density within bone marrow core biopsies, comparing patients who received or did not receive CD25-targeting immunocytokine (denileukin diftitox). (B) Box-and-whisker plots showing the distribution of CD56 positive NK cell density within bone marrow core biopsies, comparing patients who received or did not receive total body irradiation (TBI).